Provided herein are methods of treating, preventing and/or managing sarcoidosis by the administration of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-4-acetylaminoisoindolin-1,3-dione, alone or in combination with other therapeutics.ゼルディス,ジェローム,ビー....
One of the major drawbacks to STI screening is the discomfort people feel when asking their healthcare provider for a test. Some people may even avoid testing for years until the infection suddenly turns severe and becomes more difficult to treat. For this reason, some public health officials h...
TNF-A binds to special molecules known as TNF receptors (TNFRI and TNFRII) in cell membranes to activate inflammatory signals and release otherproinflammatorycytokines. TNF inhibitors bind to TNF-A and prevent its binding to the receptors and consequently, prevent the activation of inflammatoryimmune...
Other (hematologic/immune): Hemolytic anemia, aplastic anemia, hemophagocytic lymphohistiocytosis, systemic inflammatory response syndrome, histiocytic necrotizing lymphadenitis (Kikuchi lymphadenitis), sarcoidosis, immune thrombocytopenia, solid organ transplant rejection, other transplant (including corneal graft) re...
Trastuzumab, a humanised monoclonal antibody targeting the extracellular domain of the HER-2/neu protein and used to control certain breast cancers,48can have severe adverse effects, which include congestive heart failure and cardiac dysfunction while there are cases of patients who have developed leuka...
9 RegisterLog in Sign up with one click: Facebook Twitter Google Share on Facebook EMB (redirected fromEndomyocardial biopsy) Medical Category filter: AcronymDefinition EMBEmbassy EMBEmbedded EMBEngineering in Medicine and Biology(various organizations) ...
Giamarellou H (2010) Multidrug-resistant Gram-negative bacteria: how to treat and for how long. Int J Antimicrob Agents. 36 (Suppl 2):S50-S54.Giamarellou, H. (2010). Multidrug-resistant Gram-negative bacteria: how to treat and for how long. Int. J. Antimicrob. Agents 36, 50-54. ...
In the present application, a method for treating pulmonary sarcoidosis is disclosed. A patient in need of treatment for pulmonary sarcoidosis is administered a therapeutically effective amount of a mucolytic agent such as DNase I. In some embodiments, DNase I is a recombinant human DNase I such ...
After 4 weeks of detoxification, supportive treatment, and the administration of quetiapine to treat alcohol-related hallucinations and delusions, his cardiac enzymes had returned to normal and his liver enzymes had improved, but the eosinophil count had increased dramatically. Case report of ...